Details of the Drug Metabolized by Drug-Metabolizing Enzyme (DME)

General Information of Drug (ID: DR1013)
Drug Name
Medrysone
Synonyms
Medriabioptal; Medrifar; Medrisona [INN-Spanish]; Medrisone [DCIT]; Medritonic; Medriusar; Medrocort; Medroftal; Medrysonum [INN-Latin]; Sedesterol; D2UFC189XF; Hydroxymesterone; Spectramedryn; U 8471; U-8471; Visudrisone; medrysone; 11beta-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione; 2668-66-8; 6alpha-Methyl-11beta-hydroxyprogesterone; CHEBI:34829; CPD000058693; DSSTox_CID_25371; DSSTox_GSID_45371; DSSTox_RID_80833; GSH 1043; HMS; HMS Liquifilm; MLS000028714; NSC-63278; SMR000058693; UNII-D2UFC189XF
Indication Eyelid inflammation [ICD11: 9A02] Approved [1]
Structure
3D MOL 2D MOL
Pharmaceutical Properties Molecular Weight 344.5 Topological Polar Surface Area 54.4
Heavy Atom Count 25 Rotatable Bond Count 1
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 3
Cross-matching ID
PubChem CID
247839
PubChem SID
109976 ; 7849348 ; 7979880 ; 9395740 ; 10321190 ; 11466771 ; 11467891 ; 11486401 ; 11533031 ; 14827409 ; 17395643 ; 24896551 ; 30046333 ; 46506584 ; 47276848 ; 47425535 ; 47500776 ; 47647746 ; 48020242 ; 48170674 ; 49698627 ; 50124175 ; 50322454 ; 56423131 ; 57400476 ; 71825554 ; 85148347 ; 85788382 ; 89850274 ; 92125692 ; 95613570 ; 103771156 ; 103913670 ; 104170097 ; 104493518 ; 121362376 ; 121363363 ; 124583836 ; 124800109 ; 128027553 ; 134338310 ; 134983239 ; 137001649 ; 144204077 ; 160963601 ; 170465194 ; 172080722 ; 175266363 ; 175611984 ; 178103664
ChEBI ID
CHEBI:34829
CAS Number
2668-66-8
TTD Drug ID
D04SFH
Formula
C22H32O3
Canonical SMILES
CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)CC4)C)O)C)C(=O)C
InChI
1S/C22H32O3/c1-12-9-15-17-6-5-16(13(2)23)22(17,4)11-19(25)20(15)21(3)8-7-14(24)10-18(12)21/h10,12,15-17,19-20,25H,5-9,11H2,1-4H3/t12-,15-,16+,17-,19-,20+,21-,22+/m0/s1
InChIKey
GZENKSODFLBBHQ-ILSZZQPISA-N
The Metabolic Roadmap of This Drug
The Full List of Drug Metabolites (DM) of This Drug
DM Name DM ID PubChem ID Reaction DM Level REF
Medrysone metabolite M1 DM001085 N. A. Unclear 1 [3]
Medrysone metabolite M2 DM001086 N. A. Unclear 1 [3]
Medrysone metabolite M3 DM001087 N. A. Unclear 1 [3]
Medrysone metabolite M4 DM001088 N. A. Unclear 1 [3]
Medrysone metabolite M5 DM001089 N. A. Unclear 1 [3]
Medrysone metabolite M6 DM001090 N. A. Unclear 1 [3]
Medrysone metabolite M7 DM001091 N. A. Unclear 1 [3]
The Full List of Metabolic Reaction (MR) of This Drug
MR ID Reactant Product MR Type DME REF
MR001623 Medrysone Medrysone metabolite M1 Unclear CYP [3]
MR001624 Medrysone Medrysone metabolite M2 Unclear Unclear [3]
MR001625 Medrysone Medrysone metabolite M3 Unclear Unclear [3]
MR001626 Medrysone Medrysone metabolite M4 Unclear Unclear [3]
MR001627 Medrysone Medrysone metabolite M5 Unclear Unclear [3]
MR001628 Medrysone Medrysone metabolite M6 Unclear Unclear [3]
MR001629 Medrysone Medrysone metabolite M7 Unclear Unclear [3]
⏷ Show the Full List of 7 MR(s)
Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug
DME Name DME Info Species Uniprot ID EC Number REF
Cytochrome P450 3A4 (CYP3A4) DME0001 Homo sapiens
CP3A4_HUMAN
1.14.14.55
[2]
References
1 Medrysone was approved by FDA. The 2020 official website of the U.S. Food and Drug Administration.
2 Regulation of drug-metabolizing cytochrome P450 enzymes by glucocorticoids. Drug Metab Rev. 2010 Nov;42(4):621-35.
3 New Anti-Inflammatory Metabolites by Microbial Transformation of Medrysone PLoS One. 2016 Apr 22;11(4):e0153951. doi: 10.1371/journal.pone.0153951.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.